Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andre H Goy

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Frontiers in Oncology|March 31, 2025
Next-generation sequencing guides diagnosis and treatment in a complex presentation of ALK-positive anaplastic large-cell lymphoma: a case reportTejasvini Vaid, Thomas S Gunning, Rachel Cohen, et al.
Cancers|September 9, 2022
Improved Survival of Lymphoma Patients with COVID-19 in the Modern Treatment and Vaccination EraAlexandra Della Pia, Charles Zhao, Parul Jandir, et al.
Journal of the National Cancer Institute|January 2, 2017
Recommendations for Clinical Trial Development in Mantle Cell LymphomaStephen E Spurgeon, Brian G Till, Peter Martin, et al.
Frontiers in Oncology|July 1, 2022
Reliability of Cell-Free DNA and Targeted NGS in Predicting Chromosomal Abnormalities of Patients With Myeloid NeoplasmsAndrew Ip, Alexandra Della Pia, Gee Youn Geeny Kim, et al.
The Journal of Infectious Diseases|October 21, 2006
Dose-related safety and immunogenicity of baculovirus-expressed trivalent influenza vaccine: a double-blind, controlled trial in adult patients with non-Hodgkin B cell lymphomaAmar Safdar, M Alma Rodriguez, Luis E Fayad, et al.
Leukemia & Lymphoma|September 23, 2023
Phase 1b dose-finding study of rituximab, lenalidomide, and ibrutinib (R2I) in patients with relapsed/refractory mantle cell lymphomaAndrew Ip, Alessandra Petrillo, Alexandra Della Pia, et al.
Plos One|December 1, 2022
Anti-spike antibody response to the COVID vaccine in lymphoma patientsAlexandra Della Pia, Gee Youn Geeny Kim, Andrew Ip, et al.
Frontiers in Oncology|September 4, 2024
Prevalence of non-Hodgkin lymphoma patients at high-risk of failure after CAR T-cell therapy eligible for bridging radiation therapyAdnan Danish, Alexandra Della Pia, Lindsay Fogel, et al.
Transplantation and Cellular Therapy|May 9, 2021
Safety and Efficacy of Consolidation Therapy with Ipilimumab Plus Nivolumab after Autologous Stem Cell TransplantationAlan P Skarbnik, Michele L Donato, Rena Feinman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 1, 2026
CAR T-Cell Therapy for Cancer: Updates and Challenges for Response AssessmentDorine de Jong, Jeremy P McGale, Timothy J Robinson, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Frontiers in Oncology|March 31, 2025
Next-generation sequencing guides diagnosis and treatment in a complex presentation of ALK-positive anaplastic large-cell lymphoma: a case reportTejasvini Vaid, Thomas S Gunning, Rachel Cohen, et al.
Cancers|September 9, 2022
Improved Survival of Lymphoma Patients with COVID-19 in the Modern Treatment and Vaccination EraAlexandra Della Pia, Charles Zhao, Parul Jandir, et al.
Journal of the National Cancer Institute|January 2, 2017
Recommendations for Clinical Trial Development in Mantle Cell LymphomaStephen E Spurgeon, Brian G Till, Peter Martin, et al.
Frontiers in Oncology|July 1, 2022
Reliability of Cell-Free DNA and Targeted NGS in Predicting Chromosomal Abnormalities of Patients With Myeloid NeoplasmsAndrew Ip, Alexandra Della Pia, Gee Youn Geeny Kim, et al.
The Journal of Infectious Diseases|October 21, 2006
Dose-related safety and immunogenicity of baculovirus-expressed trivalent influenza vaccine: a double-blind, controlled trial in adult patients with non-Hodgkin B cell lymphomaAmar Safdar, M Alma Rodriguez, Luis E Fayad, et al.
Leukemia & Lymphoma|September 23, 2023
Phase 1b dose-finding study of rituximab, lenalidomide, and ibrutinib (R2I) in patients with relapsed/refractory mantle cell lymphomaAndrew Ip, Alessandra Petrillo, Alexandra Della Pia, et al.
Plos One|December 1, 2022
Anti-spike antibody response to the COVID vaccine in lymphoma patientsAlexandra Della Pia, Gee Youn Geeny Kim, Andrew Ip, et al.
Frontiers in Oncology|September 4, 2024
Prevalence of non-Hodgkin lymphoma patients at high-risk of failure after CAR T-cell therapy eligible for bridging radiation therapyAdnan Danish, Alexandra Della Pia, Lindsay Fogel, et al.
Transplantation and Cellular Therapy|May 9, 2021
Safety and Efficacy of Consolidation Therapy with Ipilimumab Plus Nivolumab after Autologous Stem Cell TransplantationAlan P Skarbnik, Michele L Donato, Rena Feinman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 1, 2026
CAR T-Cell Therapy for Cancer: Updates and Challenges for Response AssessmentDorine de Jong, Jeremy P McGale, Timothy J Robinson, et al.
Pageof 4